目的探讨16周内瘢痕子宫引产应用米非司酮配伍卡孕栓的治疗效果。方法从2014年1月-2015年3月医院妇产科收治的108例16周内瘢痕子宫妊娠患者中随机选取54例设为观察组,采用米非司酮联合卡孕栓治疗,将另外54例患者设为对照组,采用米司非酮联合利凡诺治疗。对比观察组和对照组患者的治疗效果。结果观察组和对照组患者均引产成功,引产成功率为100%。观察组患者引产时间、产后出血量与对照组相比明显较少,差异有统计学意义(P<0.05)。结论临床上使用米非司酮配伍卡孕栓能有效减少产妇引产时间和产后出血量,可将其作为临床16周内瘢痕子宫妊娠产妇引产的有效方法推广运用。 Objective To investigate the therapeutic effect of induction of mifepristone and carbamazepine on induced uterine scar in 16 weeks. Methods From January 2014 to March 2015, 54 cases of 108 patients with uterine scar pregnancy treated by obstetrics and gynecology in our hospital from January 2014 to March were randomly selected as observation group and treated with mifepristone combined with carbamazepine. The patients were set as the control group and were treated with mifepristone combined with rivanol. The therapeutic effects of the observation group and the control group were compared. Results Both the observation group and the control group had successful abortion, and the success rate of induction of labor was 100%. The induction of labor in observation group patients, postpartum hemorrhage was significantly less than the control group, the difference was statistically significant (P <0.05). Conclusion The clinical use of mifepristone compatibility with carbamazepine can effectively reduce the maternal induction of labor time and postpartum hemorrhage, which can be used as an effective method of maternal labor induction of scar uterine pregnancy within 16 weeks.